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 Subcutaneous anticoagulant medications like Heparin and Low-Molecular Weight 
Heparin are injections that readily cause bruising, pain, induration, and hematoma formation at 
the injection site. It is known that these adverse reactions can be correlated to the technique used 
to administer these medications; however, there is no established technique that reduces bruising, 
pain, induration, and hematoma formation at the site. Currently, the only protocol for 
subcutaneous Heparin and Low-Molecular Weight Heparin is that it is to be administered 
subcutaneously in the abdomen and when using a prefilled syringe, the air bubble should not be 
removed. The purpose of this study was to identify current nursing practice for the 
administration of these medications and to compare the results to researched techniques that 
resulted in less adverse site reactions. A total of 33 participants were recruited. The survey 
targeted six researched techniques found, after a comprehensive literature review, to have 
reduced site adverse effects associated with subcutaneous Heparin and Low-Molecular Weight 
Heparin. After completing the survey, it was found that current practice does not reflect 
techniques researched to reduce bruising, pain, induration, and hematoma formation at the site. 
In fact, very few completed one of the six research techniques that were questioned, which 
included: a two minute application of a cold compress/pack before and/or after the injection, an 
injection duration lasting 30 seconds, slow removal of the needle over five seconds, application 
of pressure after the injection for a minimum of 30 seconds, use of a hot pack/compress after the 
injection, and the use of a3 mL syringe. It was also found that there were inconsistencies in 
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CHAPTER 1: INTRODUCTION 
 A venous thromboembolism is a clot that develops in at risk patients and can lead to a 
pulmonary embolism, pulmonary hypertension, chronic venous insufficiency, stroke, or 
myocardial infarction, which can ultimately result in death (Wipke-Tevis & Rich, 2011). Heparin 
and Low Molecular Weight Heparins (LMWH) (i.e Enoxaparin, Reviparin, and Nadroparin) are 
prophylactic anticoagulant injections administered subcutaneously for the prevention of such 
thrombi. Heparin works by activating the enzyme antithrombin III, while LMWH’s potentiate 
the effects of antithrombin on factor Xa and thrombin. Both inhibit thrombin and prolong 
coagulation time, ultimately preventing the enlargement of pre-existing clots and the formation 
of new clots (Adams & Urban, 2013; Vallerand, Sanoski, & Deglin, 2011).   
 Administration of subcutaneous Heparin and LMWH can lead to hematoma formation, 
local site induration, and often causes bruising and pain at the injection site (Prater, Lenox, 
Renner, Tallmadge, & Von Lunen, 2013; Zaybak & Khorshid, 2008). Bruising, induration, and 
hematoma formation at the injection site can consequently limit the availability of that site for 
future injections and cause physiological discomfort to the patient (Kuzu & Ucar, 2001). Pain 
and bruising can also cause anxiety, disruption of body image, and patient rejection of 
subsequent injections (Avsar & Kasikci, 2013).   
 Akpinar and Celebioglu (2008), Palese, Aidone, Dante, and Pea (2013), and 
Pourghaznein, Azimi, and Jafarabadi (2014) agree that these adverse reactions at the injection 
site are directly related to the technique used to administer these medications; however, there is 
no standard technique to administer Heparin and LMWH that reduces the likeliness of these 
adverse reactions from occurring. Current protocol is that Heparin and LMWH medications are 
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to be administered subcutaneously, preferably in the abdomen, and if the medication is provided 
via a prefilled syringe from the pharmacy, the air bubble is not to be removed; no further 
instructions are provided. The abdomen is used for proper absorption, and air bubbles are in the 
provided prefilled syringes to prevent leaking of Heparin or LMWH through the subcutaneous 
tissue and onto the skin surface (Wooldridge & Jackson, 1988).  
 Standard subcutaneous injection techniques include: washing hands and cleansing the 
injection site prior to administration, angle insertion of needle between 45 and 90 degrees 
depending on the amount of subcutaneous tissue that is able to be pinched, insertion of needle 
into subcutaneous tissue without aspiration, and application of gentle pressure, ensuring the site 
is not rubbed or massaged after medication is injected slowly (Hall, 2013).  How long pressure 
should be held and over how many seconds the medication should be injected for subcutaneous 
injections is not indicated.  
 Injection techniques that reduce bruising, pain, induration and hematoma formation at the 
injection site have been researched. They have not been adopted as the standard practice for 
administering these medications. Therefore, the purpose of this study is to identify what current 
nursing practice is for administering Heparin and LMWH, and how current techniques compare 
to researched techniques that reduce site adverse reactions. This study was conducted via an 
emailed electronic and voluntary survey administered to nurses on the University of Central 
Florida’s Theta Epsilon chapter of Sigma Theta Tau Honor Society of Nursing list-serve and the 





CHAPTER 2: REVIEW OF LITERATURE 
Injection Duration and Needle Removal 
 Zaybak and Khorshid (2008) studied the effect of duration of the injection on bruising 
and pain on 50 patients who were hospitalized on neurology, orthopedic and cardiology units. 
Heparin was injected for 10 seconds on the right side of the abdomen and for 30 seconds on the 
left side. Bruising occurred in 64% (32) of the patients who received the injection over 10 
seconds compared to only 42% (21) who received the 30-second injection time. The mean 
bruising size for the control group was 109.20 mm2 48 hours after the injection and 110.12  
mm2 72 hours after the injection. The mean bruising size for the experimental group was, 
respectively, 18.76 and 21.72 mm2. Pain was significantly reduced in intensity and length in 
those who received the experimental injection.   
 Palese, Aidone, Dante, and Pea (2013) conducted a similar study that also looked at 
injection duration effects on bruising and pain on 15 patients with 300 injections total. They too 
compared a 10 second injection to a 30 second injection. Out of 300 injections, 87 bruises were 
observed: 57 of 150 occurred after injecting the medication over 10 seconds and 30 of 150 
occurred after injecting the medication over 30 seconds. Palese, Aidone, Dante, and Pea, 
however, found no difference in bruise size between the two treatments. The average size 
difference between the 10 second injection and the 30 second injection was 0.095 mm2.  
 Pourghaznein, Azimi, and Jafarabadi (2013) conducted a study that analyzed injection 
duration and also needle removal time on 90 patients on two intensive care units (ICU). Using 
four different methods, each patient received four injections in the thighs and abdomen. The 
abdomen was divided into four quadrants and one out of the four methods (A, B, C, D) was used 
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in each of the quadrants. The thighs were sectioned into upper and lower parts. Methods A and B 
were in the right thigh and methods C and D were in the left. 
  Method A included injecting the medication over 10 seconds, method B included 
injecting the medication over 10 seconds and waiting 10 seconds before withdrawing the needle, 
method C included injecting the medication over 15 seconds and waiting five seconds before 
withdrawing the needle, and method D included injecting the medication over five seconds and 
waiting 15 seconds before withdrawing the needle. Method C resulted in the lowest frequency of 
bruising in the abdomen (24), compared to method A in the thigh that resulted in bruising in 40. 
The researchers found no significant difference in number and size of bruising in the injection 
methods between the abdomen and thighs; however, pain was significantly more severe in the 
thighs than the abdomen.  
 Akpinar and Celebioglu (2008) did a similar study that also looked at injection duration 
and also needle removal time effects on bruising in 36 patients. Method A included injecting the 
medication over 10 seconds, method B included injecting the medication over 30 seconds, and 
method C included injecting the medication over 10 seconds, but waiting 10 seconds before 
withdrawing the needle. Bruising occurred in 22 patients with the use of method B and 23 
patients using method C, compared to 32 bruises in method A. Bruising diameter was also 
reduced in methods B and C with an average of 35-55 mm2, while the average diameter for 
method A was 110 mm2.  
 Indications for use. 
 The reduction in pain that is observed when administering an injection slowly (over 30 
seconds) occurs because tissue damage is reduced. The giving strength of the drug is reduced 
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during a slower injection. Also, injecting these medications under lower pressure (over 30 
seconds) may result in less tissue trauma, contributing to lower occurrence of bruising (Zaybak 
& Khorshid, 2006). The reduced occurrence and extent of bruising that is seen when needle 
removal is prolonged (five seconds) occurs because it allows proper time for heparin absorption 
and prevents drug backflow, which results in bruising (Akpinar & Celebioglu, 2008).  It is 
protocol to give Heparin and LMWH in the abdomen, unless contraindicated. 
Cold and Hot Application 
 Kuzu and Ucar (2000) investigated the effects of a dry cold application on the occurrence 
of bruising, hematoma formation, and pain on 63 patients. Method A there was no cold 
application (17), method B a cold application was applied to the injection site five minutes prior 
to the injection (16), method C a cold application was applied to the injection site five minutes 
after the injection (15), and in method D a cold application was applied to the injection site five 
minutes prior to the injection and five minutes after (15). A total of 466 injections were 
evaluated at the 48 hour mark and 421 injections were evaluated at the 72 hour mark for 
bruising. A total of 539 injections were evaluated for pain immediately after injection.  
 With regards to bruising, there was no statistical difference among the methods; however, 
with regards to pain, pain intensity and duration was significantly less in methods B and D. In 
method B, only 26 out of 119 (21.8%) experienced moderate pain, while, in method A, 47 out of 
156 experienced moderate pain (30.1%). In method D, 27 out of 106 (25.5%) actually 
experienced no pain compared to only 9 out of 119 (5.8%) in method A.  
 The previous study was based on Ross and Soltes’ (1995) study of ice and its effects on 
hematoma formation and patient discomfort in 70 patients. The population was used as their own 
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control as each were given two injections 12 hours apart. For one of the injections, ice was 
applied for two minutes prior and after the injection. Their results showed no significant 
difference in incidence or size of hematoma, though, perception of pain was severely reduced.  
 Conversely, Akpinar (2013) studied the effects of a local dry heat application on bruising 
incidence and recovery in 33 patients. LMWH was injected into both of the upper arms. One of 
the patient’s upper arms with bruising was used as the control group, and the other arm with 
bruising was the experimental with an application of a dry heat pack 72 hours after the injection. 
 In the experimental arm, the mean size of bruising sites was 4.54 ± 4.33 cm² before the 
heat application and was 3.21 ± 3.78 cm² after the heat application, respectively compared to the 
control arm which was 6.01 ± 5.47 cm² and 5.22 ± 4.45 cm².  
 Indications for use. 
 The application of a dry cold pack for a minimum of two minutes before and after 
injection is believed to create an ice analgesia effect locally on the injection site (Ross & Soltes, 
1995); thereby, altering pain perception. The use of a hot pack on the injection site can speed 
bruising recovery. Furthermore, decreasing patient anxiety, improving body image, and 
increasing adherence to treatment. It is believed that the use of a heat application after 48-72 
hours past the time of injection  increases blood circulation to the affected area via vasodilation, 
ultimately accelerating cell metabolism rate, the inflammation process, and tissue recovery time 
(Akpinar, 2013).  
Application of Pressure 
 McGowan and Wood (1989) investigated the application of pressure and aspiration 
effects on bruising incidence in 95 patients using four different methods. Aspiration is not 
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included in current protocol for administration of Heparin and LMWH, because these 
medications are given subcutaneously. This study was conducted prior to this adopted standard. 
For method A pressure was applied to the injection site for two minutes after the injection, 
method B no pressure was applied, method C the syringe was aspirated and pressure was applied 
for two minutes after the injection, and method D the syringe was aspirated. It was concluded 
that the evidence did not significantly support the hypothesis that the application of pressure 
reduced bruising size or occurrence. Despite the results of this study, Akpinar and Celebioglu 
(2008), Pourghaznein, Azimi, and Jafarabadi (2014), and Kuzu and Ucar (2001) included 
applying light pressure without rubbing the site after injections in their control groups for their 
studies of administration techniques.  
 Available textbooks for nursing students include instructions on how to administer 
Heparin and LMWH with the only significant difference from standard subcutaneous injections 
being to apply pressure for an extended period of time. Prater, Lenox, Renner, Tallmadge, and 
Von Lunen (2013), in RN Pharmacology for Nursing, instruct students to apply pressure to the 
injection site for one to two minutes after the injection. Potter, Perry, and Desmarais (2015), in 
Mosby’s Pocket Guide to Nursing Skills & Procedures place significance for the student nurse to 
administer these medications over several seconds without moving the syringe, and to apply 
pressure for 30 to 60 seconds.  
 Indications for use. 
 McGowan and Wood (1989) believe that the application of pressure causes manual 
vasoconstriction, and prevents the leakage of blood from superficial blood vessels that are 
traumatized during needle insertion. Potter, Perry, and Desmarais (2015) also provide a rationale 
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for extended pressure application. They, too, state that pressure significantly reduces bruising at 
the injection site. Because it is included in standard subcutaneous injection protocol, pressure 
should be applied after injection. For Heparin and LMWH, the amount of time to apply pressure 
can be concluded to a minimum of 30 seconds.  
Syringe Size 
 Hadley, Chang, and Rogers (1996) studied the effects of syringe size on bruising in 29 
patients. Subjects received injections in a 1 mL or 3 mL syringe in a randomized sequence, and 
sites were assessed for bruises 24, 48, and 72 hours after injection. Bruising occurred in 69% of 
patients who received injections in a 3 mL syringe compared to 79% in a 1 mL syringe. Bruising 
size was also significantly larger with the use of the 1 mL syringe and over-time the sizing of the 
bruise increased compared to the 3 mL syringe. The mean bruise size for the 3 mL syringe was 
about 20 mm², while the 1 mL syringe produced an average bruise size of 38 mm² 24 hours after 
the injection. 72 hours after the injection, the size of the bruising for the 1 mL syringe increased 
to 70 mm² and decreased for the 3 mL syringe to about 10 mm².  
 Wooldridge and Jackson (1988) studied the effects of syringe size, change of needle and 
the use of an air bubble on bruising and induration occurrence on 50 patients with cardiovascular 
disorders. Method A included the use of a 3 mL syringe, an air bubble, and changing of needle, 
and method B included the use of a 1 mL syringe, without an air bubble or changing of needle 
for drawing Heparin into the syringe. Induration occurred twice in each of the methods, and 
bruising frequency was not found to be significantly different. The size of bruising, however, 
was different. For method A, mean bruising size for females was 38 mm², while method B 
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resulted in a mean of 50 mm². For men, bruising was smaller but there was a still a statistical 
difference. Respectively, bruising mean was 0.036 mm² and 2.1 mm².  
 Indications for use. 
 Previously, it was recommended to use a tuberculin syringe (1 mL) to provide accurate 
dosing for Heparin and LMWH, currently, Heparin is typically provided in prefilled syringes 
distributed by hospital pharmacy. However, there is a possibility of having to manually draw up 
Heparin and LMWH. The use of a 3 mL syringe when prefilled Heparin and LMWH syringes 
are not distributed results in less tissue trauma. When the area of a syringe is increased, the force 
of the substance within the syringe decreases causing less blunt trauma to vessels and tissue. This 








CHAPTER 3: METHODS 
Design and Instrument 
 This descriptive exploratory correlational study was conducted using an electronic, 
voluntary and anonymous survey. Survey questions were created from researched techniques, 
standard subcutaneous injection protocol, and current Heparin and LMWH protocol and allowed 
for multiple choice answering and free-text answers. The survey analyzed the six different 
researched techniques discussed in Chapter 2 and are as follows: 
1. Corresponds to question 7: The use of a cold pack for two minutes before and/or 
after injection to reduce site pain. 
2. Corresponds to question 12: Injection duration over 30 seconds to reduce pain and 
tissue trauma.  
3. Corresponds to question 13: Slow removal of needle (five seconds) to allow 
absorption of medication to occur to prevent bruising. 
4. Corresponds to question 15: Applying pressure for a minimum of 30 seconds to 
reduce bruising by providing manual vasoconstriction.  
5. Corresponds to question 16: Applying a hot pack to site after injection to promote 
quicker healing of bruises.  
6. Corresponds to questions 17 and 18: The use of a 3 mL syringe if the employer 
does not offer prefilled syringes with Heparin and LMWH to reduce bruising.  
 Questions one through four ask non-identifying demographic data. Other questions not 
included in the above explanation were deemed to be standard protocol for subcutaneous 
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injections and/or current protocol for subcutaneous Heparin and LMWH injections or were 
placed to enhance survey fluidity and consistency.  
A copy of the survey can be found in Appendix C. 
A table comparing standard techniques for administration versus researched suggested 
techniques can be found in Appendix D.  
Human Subjects 
 Approval was requested from the University of Central Florida’s Institutional Review 
Board (IRB), and the study was determined as not human research. Participants remained 
anonymous throughout the study and surveys were not linked with any identifying information. 
Participants were able to withdraw from the study at any time without penalty.   
Sample and Setting 
 A convenience sample of nurses from the Theta Epsilon chapter of the nursing honor 
society Sigma Theta Tau at the University of Central Florida and from the graduate nursing 
program at the University of Central Florida were invited to participate in the survey. Nurses 
were required to be at least 18 years of age, to have administered subcutaneous Heparin or 
LMWH before, and to have worked directly in patient care within the past five years. 37 
participants started the survey and 33 completed the survey. Surveys that were not completed 
were not included in the study. The participants were able to complete the survey once at a 
computer that allowed access to the email invitation.  
Procedures 
 A draft email with an invitation to participate in this study was sent to the leading 
representative of each organization. The leading representatives emailed the invitation with a 
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web-link to the self-administered survey and an explanation of research (Appendix B) on the 
researchers’ behalves to the nurses on the list-serves for the Theta Epsilon chapter of Sigma 
Theta Tau and graduate nursing program at the University of Central Florida. The survey was 
closed electronically after two weeks.  
Measurements 
 The measure used in this study was a survey created by the researchers adapted from 
researched techniques and standard protocols.  
 The survey was divided into two sections with the first section including demographic 
data, educational background, and years of experience as a nurse. The second section of the 
survey allowed for multiple choice answering and/or free-text to assess what current practice is 
for administering subcutaneous injections of Heparin and LMWH.  








CHAPTER 4: RESULTS 
Demographic Data 
 A total of 33 nurses from both list-serves participated in this study. The sample was 9% 
(n=3) male and 91% female (n=30) with ages ranging from less than 35 years of age (55%; 
n=18), 35-50 years of age (30%; n=10), and greater than 50 years of age (15%; n=5). Results 
indicated 24% (n=8) of the nurses had been practicing for 6-12 months, 6% (n=2) had been 
practicing for 1-2 years, 42% (n=14) of the nurses had been practicing for 2-10 years, and 27% 
(n=9) of then nurses had been practicing for greater than 10 years. None of the nurses had a 
Diploma or an Associate’s Degree in nursing, 67% (n=22) had a Bachelor’s of Science Degree in 
Nursing, 30% (n=10) had a Master’s Degree in Nursing, and one nurse (3%) had a Doctor of 
Philosophy in Nursing.  
Quantitative Analysis 
 In regards to standard nursing practice for the administration of subcutaneous injections, 
question five asked about hand washing prior to injection, question six asked about cleansing of 
the injection site prior to the injection, question 10 asked if the nurse aspirated, and question 14 
asked if the nurse rubbed the site after injecting the medication. Results indicated 91% (n=30) 
stated that they did wash their hands prior to administering the injection, 97% (n=32) clean the 
site with an alcohol swab prior to injection, and 3% (n=1) clean the site with a chlorhexidine 
swab, 9% (n=3) indicated that they do aspirate for this injection and 91% (n=30) stated that they 
do not aspirate for this injection, and 100% (n=33) stated that they do not rub the site after giving 
the injection.  
14 
 
 The survey asked two questions about standard protocol for administering Heparin and 
LMWH subcutaneously, including: question eight that asks about where the nurses administer 
these medications and question 11 that asks if they remove the air bubble prior to administering 
these medications if the nurses are using a prefilled syringe. Results indicated 100% (n=33) 
administer this medication in the abdomen, and 67% (n=22) do not remove the air bubble when 
using a prefilled syringe, 30% (n=10) stated that they do remove the air bubble, and one (3%) 
nurse said they were not sure if they removed the air bubble.  
 For fluidity, question nine was inserted and asked about how quickly or slowly does the 
participant insert the needle into the subcutaneous tissue. Results indicated 73% (n=24) stated 
quickly averaging less than three seconds, 3% (n=1) stated they insert the needle slowly over 
three seconds, and 24% (n=8) indicated that they inject the needle without regard for time.  
 Researched injection techniques that were reported to reduce pain, bruising, hematoma 
formation and/or pain at the injection site were asked and included: application of an ice pack 
(question seven), time taken to inject the medication (question 12), needle removal time 
(question 13), application of pressure after administration of the medication (question 15), 
application of a hot pack after the injection (question 16), and syringe size (questions 17 and 18).  
 Results indicated 100% (n=33) stated that they do not use any type of cold application 
pre- or post-injection. A total of 79% (n=26) inject the medication over 10 seconds or less, 9% 
(n=3) stated that they inject the medication between 11-29 seconds, 3% (n=1) indicated that they 
inject the medication over 30 seconds, and 9% (n=3) were unsure for how many seconds they 
inject the medication. A total 64% (n=21) stated they remove the needle quickly averaging less 
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than three seconds, 15% (n=5) stated they remove the needle slowly averaging between two to 
five seconds, and 21% (n=7) remove the needle without regard for time.  
 A total of 15% (n=5) stated they apply pressure for less than 10 seconds, 6% (n=2) apply 
pressure for 10-29 seconds, 6% (n=2) apply pressure for 30-59 seconds, 0% apply pressure for 
60 seconds or longer, and 73% (n=24) stated that they do not apply pressure to the site after 
injection. A total of 100% (n=33) stated they do not apply a dry heat pack/compress to the 
injection site after administering the injection.  
 A total of 91% (n=30) stated that at their work place, subcutaneous Heparin and LMWH 
medications are administered in a prefilled syringe, and 9% (n=3) said no. A total of 67% (n=22) 
stated they use a prefilled syringe and that self-preparation of the medication was not available, 
9% (n=3) stated that when prefilled syringes are not available, they use a 1 mL syringe, 21% 
(n=7) stated that when prefilled syringes are not available, they use a 3 mL syringe, and one 







CHAPTER 5: DISCUSSION 
Current Practice 
A breakdown by question is provided below to identify current nursing practice for the 
administration of subcutaneous Heparin and LMWH. It begins with five, corresponding to the 
number of the question on the survey. Current practice was determined by what the majority of 
nurses selected as the answer for each question. 
5. Nurses wash their hands prior to the administration of subcutaneous anticoagulant 
 medications. 
6. Nurses cleanse the injection site with an alcohol swab prior to injecting these 
 medications. 
7. Nurses do not apply an ice-pack, cold compress, or cold-pack to the injection site 
 prior/post medication injection. 
8. Nurses administer these medications in the subcutaneous tissue of the abdomen. 
9. Nurses insert the needle quickly into the subcutaneous tissue, averaging less than three 
 seconds. 
10. Nurses do not aspirate. 
11. Nurses do not remove the air bubble. 
12. Nurses inject the medication into the tissue over 10 seconds or less.  
13. Nurses remove the needle quickly from the tissue after injection, averaging less than 
 three seconds. 
14.  Nurses do not rub the site after injecting these medications. 
15.  Nurses do not apply pressure after administering these medications. 
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16.  Nurses do not use a dry heat-pack or compress on the site after injecting the 
 medication. 
17 & 18. Lastly, most nurses work at a facility in which prefilled syringes are used; 
 however, if prefilled is not available, a majority of nurses will use a 1 mL syringe.  
Subcutaneous Injection Techniques 
 A majority of the nurses participating in the survey understood what techniques are used 
when administering subcutaneous injections. This is considered fundamental nursing knowledge 
and is typically taught early in nursing curriculum. All of the nurses cleansed the injection site 
prior to injection and did not rub the site after administering the injection. Depending on area of 
practice, nurses administer subcutaneous injections daily and are expected (despite area of 
practice) to administer subcutaneous injections per protocol; however, three nurses stated that 
they do aspirate and three separate nurses stated that they do not wash their hands prior to 
administering LMWH and Heparin. This means 18% (n=6) of the nurses taking the survey do not 
administer LMWH and Heparin per standard subcutaneous injection protocol.  
Heparin and LMWH Injection Protocol 
 All nurses who participated in the survey administer Heparin and LMWH in the 
subcutaneous tissue of the abdomen; however, there was discrepancy as whether or not to 
remove the air bubble found in prefilled syringes. As stated previously, the air bubble is to not be 
removed as general protocol for Heparin and LMWH. Of the 33 participants, 30% (n=10) 
remove the air bubble, 67% (n=22) do not remove the air bubble, and one nurse was unsure if 
they remove the bubble. There was no demographic correlation among participants with similar 




 A majority of nurses are not administering Heparin and LMWH according to previously 
researched techniques to reduce bruising, pain, induration and hematoma formation at the site of 
injection; therefore, increasing the likelihood of the occurrence of these adverse reactions.   
 All participants stated that they do not use any type of cold or hot application to the 
injection site. A cold application is recommended prior/after the injection to provide an analgesic 
effect, and a hot application is recommended several hours after the injection to promote healing 
of bruises. A majority of the nurses stated that they inject the medication over 10 seconds or less, 
contrary to the recommended 30 second researched technique, and majority of the nurses also 
stated that they do not apply any sort of pressure compared to the recommendation of applying 
pressure for a minimum of 30 seconds. Also, a majority of the nurses stated that they remove the 
needle quickly from the tissue after injection (averaging less than three seconds), compared to 
the recommended technique of slow removal after five seconds. Lastly, a majority of the nurses 
use a prefilled syringe at their employer institution, and when asked if prefilled syringes were not 
used, a majority stated they used a 1 mL syringe. A 3 mL syringe is recommended to reduce 
blunt trauma to surrounding tissue.  
 There were no correlations among age, years as a nurse, or degree type that suggested a 
relationship among answers.   
Limitations 
 The sample size was small and included nurses from one University institution, limiting 
the generalizability of the study results. Due to limited time available, only 33 nurses participated 
in the study and their employer institution was not known. Nurses surveyed from a hospital unit 
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that regularly gives Heparin and LMWH would have been beneficial, but not plausible due to 
time constraints. A larger sample size that targets nurses who administer Heparin and LMWH at 
a national level would yield more accurate results.  
Recommendations for Practice and Education 
 In regards to standard administration protocol for subcutaneous injections and 
subcutaneous Heparin and LMWH, there was apparent discrepancy and possible confusion. It 
would be beneficial to provide continuing education about standard subcutaneous injections and 
infection control. Minimally, areas of practice should also provide education about established 
techniques for subcutaneous anticoagulant medications, including not to remove the air bubble.  
 In regards to researched techniques, nurses are not administering Heparin and LMWH 
medications using techniques that are suggested to reduce bruising, pain, induration, and 
hematoma formation at the injection site. It is important for nurses to be educated about research 
that enhances evidence based practice. Introduction to techniques that can reduce bruising should 
be provided to nurses and providers administering subcutaneous anticoagulant therapies since 
reduction of bruising, induration, and hematoma formation at the site enhances the ability for the 
site to be used in future injections. 
  Also, by reducing pain experienced with Heparin and LMWH, nurses can build more 
trusting relationships with patients, reduce anxiety, and promote a healthy body image in the 
patient. Techniques that should be included are: injecting the medication over 30 seconds and 
prolonging the removal of the needle by five seconds, applying a cold pack to the injection site 
prior and/or post injection for two minutes, application of a heat pack 48-72 hours after injection, 
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application of pressure at the site for 30 seconds after medication injection and needle removal, 
and the use of a 3 mL syringe when prefilled syringes are not available.  
 Finally, because there was no correlation among demographic data and answers, 
evaluation of course material about Heparin and LMWH injection technique education in schools 
should be evaluated. Findings thus suggest that because there is no discrepancy among 
demographic data, current education about these medications are insufficient. As stated 
previously, student nurses should be minimally taught the standard practice for administering 
these medications; however, introduction to researched techniques should be incorporated into 
the curriculum.  
Recommendations for Future Research 
 There is much research that can be conducted to provide evidence to support the best 
practice for administration of subcutaneous Heparin and LMWH. Further research of the above 
stated techniques should be completed for validity and for clarity (i.e. how long to apply pressure 
for). Furthermore, a technique that encompasses all of the techniques stated above should be 
examined and considered for adoption as the established practice for these medications. Results 
would indicate whether or not these practices do in fact result in a decrease of injection site 
adverse reactions associated with Heparin and LMWH.  
 Research should also be conducted to see why there is confusion about current 
established protocol for subcutaneous Heparin and LMWH. Results can be used to provide 
clarity as to why there is confusion and provide a way of means for reducing the confusion. 
Research should also be conducted about standard subcutaneous injection technique knowledge 
in nurses. This study indicated that 18% of nurses do not administer Heparin and LMWH as a 
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standard subcutaneous injection, and further research is warranted to establish why this has 
occurred.  
 Lastly, research should be conducted about current educational requirements that include 
subcutaneous Heparin and LMWH to identify reasoning as to why nurses are not administering 
this medication according to standard protocol. Results would indicate needed interventions in 
the educational curriculum that would promote the use of the standard techniques as these 








CHAPTER 6: CONCLUSION 
 Current nursing practice for the administration of subcutaneous anticoagulant 
medications reflects proper subcutaneous injection technique, but yields some confusion about 
current Heparin and LMWH protocol. Current protocol includes administering the medication as 
a standard subcutaneous injection, specifically in the abdomen, and to not remove the air bubble 
that is found when using a prefilled syringe. Current nursing practice when compared to 
researched techniques suggested to reduce site adverse reactions does not reflect researched best 
practice. In fact, very few nurses actually completed any one of the recommended techniques. 
The suggested techniques included: using a cold application before and/or after the injection to 
provide an ice analgesic effect, injecting the medication over 30 seconds to cause less tissue 
trauma, slowly removing the needle over five seconds to reduce medication leaking onto skin 
surface, application of pressure for a minimum of 30 seconds to create manual vasoconstriction, 
using a hot application/pack 48-72 hours after the injection to speed up the healing process of the 
damaged tissue from the injection, and using a 3 mL syringe when prefilled syringes are not 
provided. Lastly, generally nurses are administering subcutaneous Heparin and LMWH similarly 
to each other.  
 Recommendations include providing educational courses, seminars, etc. on standard 
protocol for the administration of subcutaneous Heparin and LMWH, and introduction of 
researched techniques suggested to reduce site adverse reactions to current nurses to enhance 
evidence based practice. Another recommendation includes modification of student nursing 
curriculum and/or education to include proper administration techniques of these medications 
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and introduction to the researched techniques so that they may become familiar with it after 
becoming a practicing nurse.  
 Research should be conducted on the six different techniques to enhance the techniques’ 
validity in reduction of site adverse reactions. Research should also be conducted to determine 
why there is confusion about standard subcutaneous injections and standard protocol for the 
administration of subcutaneous Heparin and LMWH, and to identify why student nurses are not 
learning the proper techniques for these medications and, consequently, not administering this 
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EXPLANATION OF RESEARCH 
 
Title of Project: Injection Techniques of Subcutaneous Anticoagulant Therapies   
 
Principal Investigator: Kelly Allred, PhD, RN-BC, CNE 
 
Other Investigators: Co-Investigator- Leah Morissette, Undergraduate Nursing Student 
Faculty Supervisor: Principal Investigator  
You are being invited to take part in a research study. Whether you take part is up to you.. 
 
 There is currently no universal technique to administer subcutaneous anticoagulant therapies (i.e Lovenox) 
that results in the reduction of the possible adverse reactions pain and bruising at the injection site. The 
purpose of this survey is to identify current techniques being utilized by nurses for the administration of 
anticoagulant therapies. 
 
 The survey is electronic and can be accessed by following the provided link. Please fill out the demographic 
data for the first part of the survey. The second part of the survey will require you to answer questions about 
administering anticoagulant therapy. Please answer as to what you do when administering this medication. 
There are no correct answers. Select the best answer possible.  
 
 The questionnaire should take no more than 5 minutes to complete.  
 
 The survey will be available for two weeks, at the end of this time period all participants who provide their 
email address within the survey will be entered into a drawing to receive 1 of possible 20 availble $5 
Starbucks gift cards.  
 
 
You must be 18 years of age or older, a Registered Nurse, have provided direct patient care (i.e. being a floor nurse) 
within the past five years, and have administered subcutaneous anticoagulant therapies (i.e Lovenox, Low-Molecular 
Weight Heparin, etc.).  
 
Completion of the survey will imply your consent to participate in this research study. 
 
Study contact for questions about the study or to report a problem: If you have questions, concerns, or complaints, 
contact Dr. Kelly Allred, Faculty Supervisor, College of Nursing at 407-823-0160 or by email at Kelly.Allred@Ucf.edu  
 
IRB contact about your rights in the study or to report a complaint:    Research at the University of Central Florida 
involving human participants is carried out under the oversight of the Institutional Review Board (UCF IRB). This research 
has been reviewed and approved by the IRB. For information about the rights of people who take part in research, please 
contact: Institutional Review Board, University of Central Florida, Office of Research & Commercialization, 12201 Research 















1. Gender:  
 Male  
 Female  
2. Age in years:  
 <35  
 35-50  
 >50  
3. Years as a nurse:  
 6-12 Months  
 1-2 Years  
 2-10 Years  
 >10 years  
4. Educational background:  
 Diploma  
 Associate Degree in Nursing  
 Bachelor of Science in Nursing  
 Master Degree in Nursing  














5. Prior to administration of this medication, do you wash your hands?  
 Yes  
 No  
6. How do you prepare the injection site prior to administering the medication?  
 I clean the area with an alcohol swab  
 I clean the area with soap and water  
 Other  
 I do not prepare the site prior to injection  
7. Do you apply an ice-pack, cold compress, or cold-pack to the site prior or after injecting the 
medication?  
 Yes, before (please specify type and for how long)  
 Yes, after (please specify type and for how long)  
 I do not use any type of cold application pre- or post- injection  
8. Where do you administer this medication?  
 In the subcutaneous tissue of the arm  
 In the subcutaneous tissue of the leg  
 In the subcutaneous tissue of the abdomen  
9. With regards to time, how do you insert the needle into the subcutaneous tissue?  
 Quickly (please specify in seconds)  
 Slowly (please specify in seconds)  
 I inject the needle without regard for time  




10. Do you aspirate?  
 Yes  
 No  
11. Do you remove the air bubble prior to administering the medication when using a pre-filled 
syringe?  
 Yes, I remove the air bubble  
 No, I do not remove the air bubble  
 I'm not sure  
12. For how long do you inject the medication from the syringe into the subcutaneous tissue?  
 For 10 seconds or less  
 Between 11-29 seconds  
 For 30 seconds or longer  
 I'm not sure for how long I inject the medication  
13. With regards to time, how do you remove the needle from the subcutaneous tissue?  
 Quickly (please specify in seconds)  
 Slowly (please specify in seconds)  
 I remove the needle without regard for time  
 Other  
14. Do you rub the site after injecting the medication?  
 Yes, for less than 30 seconds  
 Yes, for 30 seconds or longer  





15. Do you apply pressure to the injection site after administering the medication? 
 Yes, for less than 10 seconds  
 Yes, for 11-29 seconds 
 Yes, for 30-59 seconds  
 Yes, for 60 seconds or longer  
 No, I do not apply pressure  
16. Do you apply a dry heat-pack or compress to the injection site after injecting the medication?  
 Yes (please specify type and for how long)   
 No 




  No 
  I’m not sure 
 
18. If therapies are not distributed in a prefilled syringe, what syringe size (mL) do you use? 
 
 N/A (Use prefilled syringe) 
 3 mL 
 1 mL 
 Other 
                    














Standard Techniques for 
Administering Subcutaneous 
Heparin and LMWH 
Researched Techniques Suggested to 
Reduce Site Adverse Reactions 
 Standard subcutaneous injection 
protocol 
 
 To not remove the air bubble before 
administration of the medication when 
using a prefilled syringe 
 
 
 Administer subcutaneously in the 
abdomen 
 Two minute cold pack/compress 
before and/or after injecting the 
medication 
 




 Slowly removing the needle from the 
tissue for over 5 seconds 
 
 Application of pressure at the injection 
site after removing the needle from the 
tissue for a minimum of 30 seconds 
 
 
 Application of a hot pack/compress 
48-72 hours after the injection 
 
 Use of a 3 mL syringe when prefilled 















Selection Answer  
 
Response % 
1 Male   
 
3 9% 
2 Female   
 
30 91% 
 Total  33 100% 
2. Age in years: 
Selection Answer  
 
Response % 
1 18-34   
 
18 55% 
2 35-50   
 
10 30% 
3 >50   
 
5 15% 
 Total  33 100% 
3. Years as a nurse: 









2 1-2 Years   
 
2 6% 
3 2-10 Years   
 
14 42% 
4 >10 years   
 
9 27% 
 Total  33 100% 
4. Educational background: 
Selection Answer  
 
Response % 

















































5. Prior to administration of subcutaneous anticoagulant therapies, do you wash 
your hands? 
Selection Answer  
 
Response % 
1 Yes   
 
30 91% 
2 No   
 
3 9% 
 Total  33 100% 
6. How do you prepare the injection site prior to administering the medication? 




I clean the 


















I do not 
prepare the 













7. Do you apply an ice-pack, cold compress, or cold-pack to the site prior or 
after injecting the medication? 






















I do not use 
any type of 
cold 
application 





8. Where do you administer this medication? 































9. With regards to time, how do you insert the needle into the subcutaneous 
tissue? 




























4 Other  
 
0 0% 
 Total  33 100% 
 
 
Quickly (please specify in 
seconds) 
Slowly (please specify in 
seconds) 






















10. Do you aspirate? 
Selection Answer  
 
Response % 
1 Yes   
 
3 9% 
2 No   
 
30 91% 
 Total  33 100% 
11. Do you remove the air bubble prior to administering the medication when 
using a pre-filled syringe? 

















3 I'm not sure   
 
1 3% 
 Total  33 100% 
12. For how long do you inject the medication from the syringe into the 
subcutaneous tissue? 
























I'm not sure 
for how long 









13. With regards to time, how do you remove the needle from the 
subcutaneous tissue? 




























4 Other  
 
0 0% 
 Total  33 100% 
 
Quickly (please specify in 
seconds) 





1 3 s 
2 2 




1 second  











14. Do you rub the site after injecting the medication? 

















3 No   
 
33 100% 
 Total  33 100% 
15. Do you apply pressure to the injection site after administering the 
medication? 




































 Total  33 100% 
16. Do you apply a dry heat-pack or compress to the injection site after injecting 
the medication? 











2 No   
 
33 100% 




17. At your work place, are subcutaneous anticoagulant therapies distributed in 
a prefilled syringe? 
Selection Answer  
 
Response % 
1 Yes   
 
30 91% 
2 No   
 
3 9% 
3 I'm not sure  
 
0 0% 
 Total  33 100% 
18. If therapies are not distributed in a prefilled syringe, what syringe size (mL) 
do you use? 










2 3 mL   
 
3 9% 
3 1 mL   
 
7 21% 




I'm not sure 
what syringe 
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